Impact of the COVID-19 health crisis on psychotropic drug use in children and adolescents in France.
Adolescent psychiatry
COVID-19
Child psychiatry
Health insurance
Mental health
Psychotropic drugs
Journal
Child and adolescent psychiatry and mental health
ISSN: 1753-2000
Titre abrégé: Child Adolesc Psychiatry Ment Health
Pays: England
ID NLM: 101297974
Informations de publication
Date de publication:
16 Sep 2024
16 Sep 2024
Historique:
received:
20
12
2023
accepted:
27
08
2024
medline:
17
9
2024
pubmed:
17
9
2024
entrez:
16
9
2024
Statut:
epublish
Résumé
In 2019, the world faced a pandemic brought about by a severe acute respiratory infection caused by SARS-CoV-2 virus. The spread of this virus has profoundly affected societies, particularly in terms of their economic, human and social dimensions, as well as their healthcare systems. Several restrictive measures (reduced social interaction, periodic school closures,…) had to be taken to contain the spread of the virus. These measures have had an impact on the psychological well-being of both adults and children. The aim of this study was to assess the changes in psychotropic drugs prescriptions for children and adolescents living in Limousin, a French region, over the period 2018 to 2021. The consumption of psychotropic drugs was studied using a national database of drug reimbursement. These data were extracted and supplied from the nationwide French reimbursement healthcare system database (SNDS). The following therapeutic classes were studied: N05A (antipsychotics), N05B (anxiolytics), N05C (hypnotics and sedatives), N06A (antidepressants) and N06B (psychostimulants). Data were collected for insured persons under the age of 18 who received at least one reimbursement for a psychotropic drug between 2018 and 2021. Over a 4-year period, 7949 patients under the age of 18 were included with an average age of 12.1 years and a sex ratio of 0.97 M/F. The number of patients increased from 2018 to 2021, as did the number of reimbursements. We observed a statistically significant difference of means of patients reimbursed per week for on five therapeutic classes, with the greatest difference in 2021 (p < 0.0001). An increase in the number of patients of between + 20.7% and + 689% was observed, depending on the drug classes studied. Comparisons between the COVID-19 and pre-COVID-19 periods showed a significantly higher COVID average for psychotropic drugs reimbursements in general and individually for all classes except psychostimulants. The results show a significant increase in the consumption of psychotropic drugs among youth. The increase in psychotropic drug use was continuous and progressive throughout the pandemic. All five classes were increased, but particularly anxiolytics and antidepressants. The COVID-19 context may have been at the origin of a deterioration in the mental health of children and adolescents, or of a heightened awareness of psychiatric care among young people.
Sections du résumé
BACKGROUND
BACKGROUND
In 2019, the world faced a pandemic brought about by a severe acute respiratory infection caused by SARS-CoV-2 virus. The spread of this virus has profoundly affected societies, particularly in terms of their economic, human and social dimensions, as well as their healthcare systems. Several restrictive measures (reduced social interaction, periodic school closures,…) had to be taken to contain the spread of the virus. These measures have had an impact on the psychological well-being of both adults and children. The aim of this study was to assess the changes in psychotropic drugs prescriptions for children and adolescents living in Limousin, a French region, over the period 2018 to 2021.
METHODS
METHODS
The consumption of psychotropic drugs was studied using a national database of drug reimbursement. These data were extracted and supplied from the nationwide French reimbursement healthcare system database (SNDS). The following therapeutic classes were studied: N05A (antipsychotics), N05B (anxiolytics), N05C (hypnotics and sedatives), N06A (antidepressants) and N06B (psychostimulants). Data were collected for insured persons under the age of 18 who received at least one reimbursement for a psychotropic drug between 2018 and 2021.
RESULTS
RESULTS
Over a 4-year period, 7949 patients under the age of 18 were included with an average age of 12.1 years and a sex ratio of 0.97 M/F. The number of patients increased from 2018 to 2021, as did the number of reimbursements. We observed a statistically significant difference of means of patients reimbursed per week for on five therapeutic classes, with the greatest difference in 2021 (p < 0.0001). An increase in the number of patients of between + 20.7% and + 689% was observed, depending on the drug classes studied. Comparisons between the COVID-19 and pre-COVID-19 periods showed a significantly higher COVID average for psychotropic drugs reimbursements in general and individually for all classes except psychostimulants.
CONCLUSION
CONCLUSIONS
The results show a significant increase in the consumption of psychotropic drugs among youth. The increase in psychotropic drug use was continuous and progressive throughout the pandemic. All five classes were increased, but particularly anxiolytics and antidepressants. The COVID-19 context may have been at the origin of a deterioration in the mental health of children and adolescents, or of a heightened awareness of psychiatric care among young people.
Identifiants
pubmed: 39285493
doi: 10.1186/s13034-024-00806-z
pii: 10.1186/s13034-024-00806-z
doi:
Types de publication
Journal Article
Langues
eng
Pagination
119Informations de copyright
© 2024. The Author(s).
Références
Allocution liminaire du Directeur général de l’OMS lors du point presse sur la COVID-19 - 11 mars 2020 [Internet]. [cited 2023 Mar 22]. Available from: https://www.who.int/fr/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020
Assemblée nationale [Internet]. 2020. Compte rendu Mission d’information de la conférence des Présidents sur l’impact, la gestion et les conséquences dans toutes ses dimensions de l’épidémie de Coronavirus-Covid 19 (pouvoirs d’enquête).
Les conséquences de la crise sanitaire de la Covid-19| Insee [Internet]. [cited 2023 Mar 22]. Available from: https://www.insee.fr/fr/information/4479280
L’économie française en 2020 : une année de bouleversements - Insee Analyses - 64 [Internet]. [cited 2023 Mar 22]. Available from: https://www.insee.fr/fr/statistiques/5389038
Usage des médicaments de ville en France durant l’épidémie de la Covid-19– point de situation jusqu’au 25 avril 2021 [Internet]. [cited 2022 Jul 18]. Available from: https://www.epi-phare.fr/app/uploads/2021/05/epi-phare_rapport_6_medicaments_covid_20210527.pdf
Josephine Elia. Troubles dépressifs chez l’enfant et l’adolescent [Internet]. LE MANUEL MSD; 2021. Available from: https://www.msdmanuals.com/fr/professional/p%C3%A9diatrie/troubles-psychiatriques-chez-l-enfant-et-l-adolescent/troubles-d%C3%A9pressifs-chez-l-enfant-et-l-adolescent
vidal. Dépression chez l’enfant et l’adolescent. In 2019. Available from: https://www.vidal.fr/maladies/chez-les-enfants/depression-enfant-adolescent/sources-references.html
Site d’aide à la prescription pharmacologique - Dépression [Internet]. [cited 2022 Aug 23]. Available from: https://pharmacologie.sfpeada.fr/trouble/4/1
Site d’aide à la prescription pharmacologique - Troubles bipolaires [Internet]. [cited 2022 Aug 24]. Available from: https://pharmacologie.sfpeada.fr/trouble/1/1
Dumortier G, Welniarz B, Sauvebois C, Medjdoub H, Friche H, Siad N, et al. Prescription of psychotropic drugs in paediatry: approved indications and therapeutic perspectives. L’Encephale. 2005;31(4 Pt 1):477–89.
doi: 10.1016/S0013-7006(05)82409-1
pubmed: 16389715
Protocole sanitaire, bac 2021... Ce qui change pour la rentrée scolaire 2020 [Internet]. [cited 2023 Feb 23]. Available from: https://www.vie-publique.fr/eclairage/275791-rentree-scolaire-2020-protocole-sanitaire-decrochage-bac-2021
Laura Z. Stratégie de vaccination contre la Covid-19. 2021
Gindt M, Fernandez A, Battista M, Askenazy F. Conséquences psychiatriques de la pandémie de la Covid 19 chez l’enfant et l’adolescent. Neuropsychiatr Enfance Adolesc. 2021;69(3):115–20.
doi: 10.1016/j.neurenf.2021.01.001
pubmed: 33518881
pmcid: 7837060
Sprang G, Silman M. Posttraumatic stress disorder in parents and youth after health-related disasters. Disaster Med Public Health Prep. 2013;7(1):105–10.
doi: 10.1017/dmp.2013.22
pubmed: 24618142
Fong CV, Iarocci G. Child and family outcomes following pandemics: A systematic review and recommendations on COVID-19 policies. J Pediatr Psychol. 2020;45(10):1124–43.
doi: 10.1093/jpepsy/jsaa092
Wang C, Pan R, Wan X, Tan Y, Xu L, Ho CS, et al. Immediate Psychological Responses and Associated Factors during the Initial Stage of the 2019 Coronavirus Disease (COVID-19) Epidemic among the General Population in China. Int J Environ Res Public Health. 2020;17(5):1729.
doi: 10.3390/ijerph17051729
pubmed: 32155789
pmcid: 7084952
Adıbelli D, Sümen A. The effect of the coronavirus (COVID-19) pandemic on health-related quality of life in children. Child Youth Serv Rev. 2020;119:105595.
doi: 10.1016/j.childyouth.2020.105595
pubmed: 33071408
pmcid: 7550976
Jiao WY, Wang LN, Liu J, Fang SF, Jiao FY, Pettoello-Mantovani M, et al. Behavioral and emotional disorders in children during the COVID-19 epidemic. J Pediatr. 2020;221:264-266.e1.
doi: 10.1016/j.jpeds.2020.03.013
pubmed: 32248989
pmcid: 7127630
Zhou SJ, Zhang LG, Wang LL, Guo ZC, Wang JQ, Chen JC, et al. Prevalence and socio-demographic correlates of psychological health problems in Chinese adolescents during the outbreak of COVID-19. Eur Child Adolesc Psychiatry. 2020;29(6):749–58.
doi: 10.1007/s00787-020-01541-4
pubmed: 32363492
pmcid: 7196181
Duan L, Shao X, Wang Y, Huang Y, Miao J, Yang X, et al. An investigation of mental health status of children and adolescents in china during the outbreak of COVID-19. J Affect Disord. 2020;1(275):112–8.
doi: 10.1016/j.jad.2020.06.029
Ghosh R, Dubey MJ, Chatterjee S, Dubey S. Impact of COVID-19 on children: special focus on the psychosocial aspect. Minerva Pediatr. 2020;72(3):226–35.
doi: 10.23736/S0026-4946.20.05887-9
pubmed: 32613821
Jones SE, Ethier KA, Hertz M, DeGue S, Le VD, Thornton J, et al. Mental health, suicidality, and connectedness among high school students during the COVID-19 pandemic—adolescent behaviors and eperiences survey, United States, January–June 2021. MMWR Suppl. 2022;71(3):16–21.
doi: 10.15585/mmwr.su7103a3
pubmed: 35358165
Cui Y, Li Y, Zheng Y, Chinese Society of Child & Adolescent. Mental health services for children in China during the COVID-19 pandemic: results of an expert-based national survey among child and adolescent psychiatric hospitals. Eur Child Adolesc Psychiatry. 2020;29(6):743–8.
doi: 10.1007/s00787-020-01548-x
pubmed: 32394092
Varga TV, Bu F, Dissing AS, Elsenburg LK, Bustamante JJH, Matta J, et al. Loneliness, worries, anxiety, and precautionary behaviours in response to the COVID-19 pandemic: A longitudinal analysis of 200,000 Western and Northern Europeans. Lancet Reg Health - Eur. 2021;2:100020.
doi: 10.1016/j.lanepe.2020.100020
pubmed: 33870246
Wathelet M, Duhem S, Vaiva G, Baubet T, Habran E, Veerapa E, et al. Factors Associated With Mental Health Disorders Among University Students in France Confined During the COVID-19 Pandemic. JAMA Netw Open. 2020;3(10):e2025591.
doi: 10.1001/jamanetworkopen.2020.25591
pubmed: 33095252
Pereda N, Díaz-Faes DA. Family violence against children in the wake of COVID-19 pandemic: a review of current perspectives and risk factors. Child Adolesc Psychiatry Ment Health. 2020;14:40.
doi: 10.1186/s13034-020-00347-1
pubmed: 33088340
INSEE-Institut national de la statistique et des études économiques. Recensement de la population- évolution et structure de la population en 2020. 2023.
Santé Publique France. Des données issues du SNDS [Internet]. 2022. Available from: https://www.santepubliquefrance.fr/maladies-et-traumatismes/infections-associees-aux-soins-et-resistance-aux-antibiotiques/resistance-aux-antibiotiques/articles/des-donnees-issues-du-snds-systeme-national-des-donnees-de-sante
INSEE-Institut national de la statistique et des études économiques. Pyramide des âges: projections de population 2050 - Régions et départements Séries de 2013 à 2050 [Internet]. 2017. Available from: https://www.insee.fr/fr/statistiques/2418126
Kuitunen I, Uimonen MM, Ponkilainen VT, Mattila VM. Primary care visits due to mental health problems and use of psychotropic medication during the COVID-19 pandemic in Finnish adolescents and young adults. Child Adolesc Psychiatry Ment Health. 2023;17(1):35.
doi: 10.1186/s13034-023-00584-0
pubmed: 36895042
Kostev K, Weber K, Riedel-Heller S, von Vultée C, Bohlken J. Increase in depression and anxiety disorder diagnoses during the COVID-19 pandemic in children and adolescents followed in pediatric practices in Germany. Eur Child Adolesc Psychiatry. 2023;32(5):873–9.
doi: 10.1007/s00787-021-01924-1
pubmed: 34825964
Theuring S, van Loon W, Hommes F, Bethke N, Mall MA, Kurth T, et al. Psychosocial Wellbeing of Schoolchildren during the COVID-19 Pandemic in Berlin, Germany, June 2020 to March 2021. Int J Environ Res Public Health. 2022;19(16):10103.
doi: 10.3390/ijerph191610103
pubmed: 36011738
pmcid: 9407732
Theuring S, Kern M, Hommes F, Mall MA, Seybold J, Mockenhaupt FP, et al. Generalized anxiety disorder in Berlin school children after the third COVID-19 wave in Germany: a cohort study between June and September 2021. Child Adolesc Psychiatry Ment Health. 2023;17(1):1.
doi: 10.1186/s13034-022-00552-0
pubmed: 36597131
pmcid: 9808730
Ravens-Sieberer U, Erhart M, Devine J, Gilbert M, Reiss F, Barkmann C, et al. Child and adolescent mental health during the COVID-19 pandemic: results of the three-wave longitudinal COPSY study. J Adolesc Health Off Publ Soc Adolesc Med. 2022;71(5):570–8.
doi: 10.1016/j.jadohealth.2022.06.022
Leong C, Katz LY, Bolton JM, Enns MW, Delaney J, Tan Q, et al. Psychotropic drug use in children and adolescents before and during the COVID-19 pandemic. JAMA Pediatr. 2022;176(3):318.
doi: 10.1001/jamapediatrics.2021.5634
pubmed: 34982101
pmcid: 8728654
Estrela M, Silva TM, Gomes ER, Piñeiro M, Figueiras A, Roque F, et al. Prescription of anxiolytics, sedatives, hypnotics and antidepressants in outpatient, universal care during the COVID-19 pandemic in Portugal: a nationwide, interrupted time-series approach. J Epidemiol Community Health. 2022;76(4):335–40.
doi: 10.1136/jech-2021-216732
pubmed: 34625519
Levaillant M, Wathelet M, Lamer A, Riquin E, Gohier B, Hamel-Broza JF. Impact of COVID-19 pandemic and lockdowns on the consumption of anxiolytics, hypnotics and antidepressants according to age groups: a French nationwide study. Psychol Med. 2021;14:1–7.
Kuitunen I. Psychotropic medication use in pediatric population during COVID -19 pandemic. Acta Psychiatr Scand. 2022;146(4):381–3.
doi: 10.1111/acps.13483
pubmed: 35894545
pmcid: 9353282
Sciberras E, Patel P, Stokes MA, Coghill D, Middeldorp CM, Bellgrove MA, et al. Physical health, media use, and mental health in children and adolescents With ADHD during the COVID-19 pandemic in Australia. J Atten Disord. 2022;26(4):549–62.
doi: 10.1177/1087054720978549
pubmed: 33331195
Haut Conseil de la Famille, et l’Enfant et de l’Âge (HCFEA). Quand les enfants vont mal: comment les aider? 2023.
Courtney D, Watson P, Battaglia M, Mulsant BH, Szatmari P. COVID-19 impacts on child and youth anxiety and depression: challenges and opportunities. Can J Psychiatry Rev Can Psychiatr. 2020;65(10):688–91.
doi: 10.1177/0706743720935646
Russell BS, Hutchison M, Tambling R, Tomkunas AJ, Horton AL. Initial challenges of caregiving during COVID-19: caregiver burden, mental health, and the parent-child relationship. Child Psychiatry Hum Dev. 2020;51(5):671–82.
doi: 10.1007/s10578-020-01037-x
pubmed: 32749568
Imran N, Aamer I, Sharif MI, Bodla ZH, Naveed S. Psychological burden of quarantine in children and adolescents: A rapid systematic review and proposed solutions. Pak J Med Sci. 2020;36(5):1106–16.
doi: 10.12669/pjms.36.5.3088
pubmed: 32704298
Loades ME, Chatburn E, Higson-Sweeney N, Reynolds S, Shafran R, Brigden A, et al. Rapid systematic review: the impact of social isolation and loneliness on the mental health of children and adolescents in the context of COVID-19. J Am Acad Child Adolesc Psychiatry. 2020;59(11):1218-1239.e3.
doi: 10.1016/j.jaac.2020.05.009
pubmed: 32504808
pmcid: 7267797
Jeunes et médicaments psychotropes Enquête qualitative sur l’usage détourné [Internet]. [cited 2022 Jul 22]. Available from: http://www.ofdt.fr/BDD/publications/docs/eftxmmw5.pdf